Obsidian Therapeutics, Inc.

OBX chart

Obsidian Therapeutics, Inc. news

• Obsidian Therapeutics, Inc. Estimates – NASDAQ:OBX

  TradingView · Oct 26, 10:09 PM EDT

• Obsidian Therapeutics (Nasdaq:OBX) - Stock Analysis

  Simply Wall Street · Oct 25, 3:00 AM EDT

• Obsidian Therapeutics (NASDAQ:OBX) Upgraded to Hold at Wall Street Zen

  MarketBeat · Oct 25, 1:30 AM EDT

• Price performance

  Yahoo Finance UK · Oct 23, 4:27 PM EDT

• October 2026 Nasdaq Stock Market Bell Ceremonies

  Nasdaq · Oct 23, 3:00 AM EDT

• Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting

  Yahoo Finance · Oct 2, 9:05 AM EDT

• Obsidian Therapeutics (OBX) Stock Dropped, So What Is Behind The Attention Now?

  Yahoo Finance · Aug 12, 9:11 PM EDT

• Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls

  Yahoo Finance · Aug 6, 9:48 AM EDT

• Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

  Yahoo Finance · Aug 5, 9:40 AM EDT

• Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma

  Yahoo Finance · Aug 5, 7:05 AM EDT

Obsidian Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• S-1S-12026-08-28
• 8-K/A8-K/A2026-08-14
• 10-Q10-Q2026-08-14
• 8-K8-K2026-08-03

About Obsidian Therapeutics, Inc.

Ticker

OBX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Cambridge, MA

Fiscal year end

December 31

SEC CIK

2130606

Former names

Gazelle Parent, Inc.

Frequently asked questions